Cargando…
Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials
The ongoing pandemic of coronavirus disease-2019 (COVID-19) is being caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The disease continues to present significant challenges to the health care systems around the world. This is primarily because of the lack of vaccines to prote...
Autores principales: | Al-Horani, Rami A., Kar, Srabani, Aliter, Kholoud F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432953/ https://www.ncbi.nlm.nih.gov/pubmed/32718020 http://dx.doi.org/10.3390/ijms21155224 |
Ejemplares similares
-
Potential Anti-SARS-CoV-2 Therapeutics That Target the Post-Entry Stages of the Viral Life Cycle: A Comprehensive Review
por: Al-Horani, Rami A., et al.
Publicado: (2020) -
Sulfonated Nonsaccharide Heparin Mimetics Are Potent
and Noncompetitive Inhibitors of Human Neutrophil Elastase
por: Al-Horani, Rami A., et al.
Publicado: (2021) -
Sulphated penta-galloyl glucopyranoside (SPGG) is glycosaminoglycan mimetic allosteric inhibitor of cathepsin G
por: Al-Horani, Rami A, et al.
Publicado: (2023) -
Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19
por: Aliter, Kholoud F., et al.
Publicado: (2020) -
Discovery of Benzyl Tetraphosphonate Derivative as Inhibitor of Human Factor Xia
por: Kar, Srabani, et al.
Publicado: (2020)